Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

李沛璋 (Pei-Chang Lee)

李沛璋(Pei-Chang Lee)圖 Return Appointment First Appointment

[Profile]

  • Education
    • 學士, 醫學系; 國立陽明大學,
    • 博士, 藥理學研究所; 國立陽明大學,
  • Career and Experience
    Current Positions：
    • - Now, 主治醫師, 內科部胃腸肝膽科, 臺北榮民總醫院,
    • - Now, 助理教授, 國立陽明大學醫學系,
    Experiences：
    • - , 主治醫師, 內科部, 員山榮民醫院,
    • - , 總住院醫師, 胃腸肝膽科, 台北榮民總醫院,
    • - , 住院醫師, 內科部, 台北榮民總醫院,
  • Medical Expertise
    1. 肝硬化、肝癌、壺腹及十二指腸癌、膽胰疾病、臨床營養學。
  • License
    內科專科醫師 消化專科醫師 內視鏡專科 腸道暨靜脈營養專科醫師
  • Language Expertise
    中文 英文 台語

[Publications]

1. Lee PC, Wu CJ, Hung YW, Lee CJ, Chi CT, Lee IC, Kuo YL, Chou SH, Luo JC, Hou MC, Huang YH. Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma. J Immunother Cancer. 2022 Jun; 10(6):e004779.
2. Lee PC, Hsieh YC, Huo TI, Yang UC, Lin CH, Li CP, Huang YH, Hou MC, Lin HC, Lee KC. Active Vitamin D3 Treatment Attenuated Bacterial Translocation via Improving Intestinal Barriers in Cirrhotic Rats. Mol Nutr Food Res. 2021 Feb;65(3):e2000937.
3. Lee PC, Chang TE, Wang YP, Lee KC, Lin YT, Chiou JJ, Huang CW, Yang UC, Li FY, Huang HC, Wu CY, Huang YH, Hou MC. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection. J Formos Med Assoc. 2021 Nov 23;S0929-6646(21)00498-8.
4. Lee PC, Chao Y, Chen MH, Lan KH, Lee IC, Hou MC, Huang YH. Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma. J Immunother Cancer. 2020 Aug;8(2):e001072.
5. Lee PC, Chao Y, Chen MH, Lan KH, Lee CJ, Lee IC, Chen SC, Hou MC, Huang YH. Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma. Cancers (Basel). 2020 Jan 11;12(1). 

回到最上